221 Matching Annotations
  1. Last 7 days
    1. 64-year-old man carrying the VHL gene mutation affected by simultaneous colon adenocarcinoma, renal clear cell carcinoma and adrenal pheochromocytoma.

      PatientID: None

      KindredID: 1

      Case: M, 75Y0M, Ethnicity Unknown

      DiseaseAssertion: VHL

      FamilyInfo: The patient's brother had hypertension at age 77 and was found to carry the mutation. The patient's niece had breast cancer at age 33. Refer to Figure 4 for Pedigree.

      CasePresentingHPOs: HP:0006770, HP:0040276, HP:0006748, HP:0001407, HP:0002716, HP:0032618, HP:0100526, HP:0100598 (clear cell renal cell carcinoma, adenocarcinoma of the colon, adrenal pheochromocytoma, hepatic cysts, lymphadenopathy, renal necrosis, neoplasm of the lung, pulmonary edema)

      CaseHPOFreeText: Patient admitted at age 64 for intermittent abdominal pain, loss of appetite and constipation. He was found to have a solid tumor with areas of colliquative necrosis in the upper pole of the left kidney. The scans also showed distension of the colon with concomitant wall thickening, indicating possible neoplasia. Colonoscopy revealed a small polyp in the rectum-sigmoid junction, and a subsequent histological exam confirmed a diagnosis of adenocarcinoma. Both tumours were removed via a left hemicolectomy and left radical nephrectomy. A histologic examination of the kidney revealed renal clear cell carcinoma. Five years later, an abdominal CT scan revealed an adrenal pheochromocytoma in the right adrenal gland and multiple hepatic cysts in the right kidney and liver. The patient underwent a right adrenalectomy which found no convincing evidence of malignancy. At age 73 total body positron emission tomography (PET)-CT revealed the presence of several metastatic sites (both lungs, a 12×10 mm right sovraclaveare lymphadenopathy, and a 32×12 mm lesions at the mediastinum). An agobiopsy and cytologic broncholavage showed lymphocytes and epithelial cells with voluminous clear cytoplasm and large nuclei with prominent nucleoli, confirming the presence of metastatic lesions of clear cell renal carcinoma. In the same year, CT imaging revealed progression of pulmonary disease. One year later, a new CT scan revealed hepatic metastases and worsening of the mediastinal adenopathy and pulmonary metastases. At age 75, a new CT scan showed stable disease at various metastatic sites with minimal pleural effusion. Later in the month the patient was hospitalized for severe dyspnea, fatigue, and lower limb edema and died a few days later.

      CaseNotHPOs: HP:0009711 (retinal capillary hemangioma)

      CaseNotHPOFreeText: Fundoscopy revealed no vascular abnormalities of the retina.

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.P25L (c.74C>T)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: 93330 https://www.ncbi.nlm.nih.gov/clinvar/variation/93330/

      CAID: N/A

      gnomAD: 0.002988 https://gnomad.broadinstitute.org/variant/3-10183605-C-T

      VariantEvidence: N/A

      MutationType: missense_variant;transition

      CivicName:P25L (c.74C>T)

      MultipleGeneVariants: N/A

    1. PatientID: 30

      KindredID: 20

      Case: F, 26Y0M, Indian

      DiseaseAssertion: VHL

      FamilyInfo: Relevant family history but details are not made available.

      CohortInfo: This retrospective study was conducted at Department of Endocrinology of a tertiary care health centre in Western India. Patients presented to our institute between 2008 and 2016 were included in the study. During the study period a total of 33 patients were suspected to have VHL syndrome based on clinical features among whom 31 patients were found to have mutation in VHL gene. All patients are of Asian Indian descent.

      CasePresentingHPOs: HP:0002666; HP:0001737; HP:0005584, HP:0010797 (Pheochromocytoma, Pancreatic cysts, Retinal capillary hemangioma, Hemangioblastoma)

      CaseHPOFreeText: Unilateral pheochromocytoma.

      CaseNotHPOs: HP:0002668; HP:0009711; HP:0030405 (Paraganglioma, Renal cell carcinoma, Pancreatic endocrine tumor)

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: Exon 1-3 Deletion (c.1-?_642+?del)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: N/A

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: exon_loss_variant

      CivicName: Exon 1-3 Deletion

      MultipleGeneVariants: N/A

    1. c.74C>T, p.P25L

      PatientID: II-1

      KindredID: Family C

      Case: M, 45Y0M, Ethnicity unknown

      DiseaseAssertion: VHL

      FamilyInfo: Only this one member was studied at have the L198P mutation, however the asymptomatic father of patient C II-1 was also a carrier of the same polymorphism (c.74C>T, p.P25L).

      CasePresentingHPOs: HP:0006748; HP:0030405; HP:0009711 (Adrenal pheochromocytoma; pancreatic neuroendocrine tumour; retinal capillary hemangioma)

      CaseHPOFreeText: At the age of 15, patient had pancreatic tumor (malignant pancreatic neuroendocrine tumor). At the age of 16, MRI revealed suprarenal tumor masses bilaterally (pheochromocytomas in the adrenal glands), as well as optic nerve hemangioblastomas of the right eye. At the age of 25, he shows no signs of metastases or new VHL-associated tumors, but since the age of 23, he has been suffering from HLAB27-positive ankylosing spondylitis.

      CaseNotHPOs: HP:0005584; HP:0010797 (renal cell carcinoma; hemangioblastoma)

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.P25L (c.74C>T)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: 93330 https://www.ncbi.nlm.nih.gov/clinvar/variation/93330/

      CAID: N/A

      gnomAD: 0.002988 https://gnomad.broadinstitute.org/variant/3-10183605-C-T

      VariantEvidence: N/A

      MutationType: missense_variant;transition

      CivicName: L198P (c.593T>C) AND P25L (c.74C>T)

      MultipleGeneVariants: Germline, VHL, c.593T>C (p.Leu198Pro)

    1. PatientID: None

      KindredID: 1

      Case: Sex Unknown, Age Unknown, Ethnicity Unknown

      DiseaseAssertion: Adrenal pheochromocytoma

      FamilyInfo: The proband was part of a cohort of apparently sporadic cases of pheochromocytoma/ paraganglioma, implying this individual had no family history of VHL disease or pheochromocytoma.

      CasePresentingHPOs: HP:0006748 (Adrenal Pheochromocytoma)

      CaseHPOFreeText: N/A

      CaseNotHPOs: HP:0002668 (Paraganglioma)

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: RET, SDHB, SDHC, and SDHD

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.P25L (c.74C>T)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: 93330, https://www.ncbi.nlm.nih.gov/clinvar/variation/93330/

      CAID: N/A

      gnomAD: 0.002988, https://gnomad.broadinstitute.org/variant/3-10183605-C-T?dataset=gnomad_r2_1

      VariantEvidence: N/A

      MutationType: missense_variant;transition

      CivicName: P25L (c.74C>T)

      MultipleGeneVariants: N/A

    1. nonsense mutations (6/16)

      PatientID: 3

      KindredID: 3

      Case: 27Y0M, Sex Unknown, Argentinian

      DiseaseAssertion: VHL

      FamilyInfo: No family history

      CasePresentingHPOs: HP:0010797; HP:0006770; HP:0001737; HP:0000107; HP:0030424 (hemangioblastoma; clear cell renal cell carcinoma; pancreatic cysts; renal cyst; epididymal cyst)

      CaseHPOFreeText: Aged 20Y at diagnosis (genetic testing); fulfils type 1 VHL clinical diagnosis. CNS angiomas diagnosed at 20, 25, and 26Y, pancreatic, renal, and epididymal cysts diagnosed at 25Y, ccRCC diagnosed at 27Y. (See Table 1 & 2).

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.R161* (c.481C>T)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: 2217 https://www.ncbi.nlm.nih.gov/clinvar/variation/2217/

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: stop_gained

      CivicName: R161* (c.481C>T)

      MultipleGeneVariants: N/A

    1. 12PCCF25+VHL30Uni−− VHL 3Germlinec.499C>Tp.Arg167TrpPathogenic

      PatientID: 12

      KindredID: 2

      Case: F, 25Y0M, Ethnicity Unknown

      DiseaseAssertion: VHL

      FamilyInfo: Patient has 2 siblings (patients 10 and 11) with the same mutation and pheochromocytoma.

      CasePresentingHPOs: HP:0002666 (Pheochromocytoma)

      CaseHPOFreeText: Unilateral pheochromocytoma (30mm)

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: SDHB (NM_003000.2), SDHC (NM_003001.3), SDHD (NM_003002.2), SDHAF2 (NM_017841.2), RET (exons 10–11 and 13–16, NM_020975.4), TMEM127 (NM_017849.3), MAX (NM_002382.3).

      PreviouslyPublished: N/A

      SupplementalData: Table 2

      Variant: p.R167W (c.499C>T)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: 2218, https://www.ncbi.nlm.nih.gov/clinvar/variation/2218/

      CAID: N/A

      gnomAD: 0.000007954, https://gnomad.broadinstitute.org/variant/3-10191506-C-T

      VariantEvidence: Loss of heterozygosity could be detected in tumour DNA.

      MutationType: missense_variant;transition

      CivicName: R167W (c.499C>T)

      MultipleGeneVariants: N/A

    1. III/6 (44)-----Pro25Leu

      PatientID: IIII-6

      KindredID: 1

      Case: F, 44Y0M, Hungarian

      DiseaseAssertion: Asymptomatic

      FamilyInfo: The patient's mother (II-5) carried the Ser80Asn mutation and presented with renal cell carcinoma. The patient's siblings (III-7 and III-8) both carried the Ser80Asn mutation. Patient III-7 presented with hemangioblastoma of the brain and retina hemangioblastoma and her children carried the Ser80Asn mutation with clinical presentation. Patient III-8 presented with brain hemangioblastoma, pheochromocytoma, and retina hemangioma. The patient's maternal aunt (II-1) carried both Ser80Asn and Pro25Leu mutation but was asymptomatic. She passed on the Ser80Asn mutation to her daughter (III-1), the proband and this patient's cousin. Refer to figure 1 for pedigree.

      CasePresentingHPOs: N/A

      CaseHPOFreeText: N/A

      CaseNotHPOs: HP:0005584, HP:0002666, HP:0010797, HP:0009711 (renal cell carcinoma, pheochromocytoma, hemangioblastoma, retinal capillary hemangioma)

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.P25L (c.74C>T)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: 93330 https://www.ncbi.nlm.nih.gov/clinvar/variation/93330/

      CAID: CA020538 http://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvsOrDescriptor=NM_000551.3%3Ac.74C%3ET

      gnomAD: 0.002988 https://gnomad.broadinstitute.org/variant/3-10183605-C-T

      VariantEvidence: N/A

      MutationType: missense_variant;transition

      CivicName:P25L (c.74C>T)

      MultipleGeneVariants: N/A

    1. PatientID: 231

      KindredID: 86

      Case: M, 54Y0M, Chinese

      DiseaseAssertion: VHL

      FamilyInfo: The proband (patient 229) had a sister (patient 230) who was genetically confirmed with the mutation, and presented with a CNS hemangioblastoma at age 40. The proband's brother 1 (patient 231) was also confirmed with the mutation and had a retinal angioma at 25, and renal cell carcinoma at 54. The proband's brother 2 passed away before they could be diagnosed/ confirmed with the mutation, but they had a CNS hemangioblastoma at 35. Finally, the proband's nephew (son of brother 2) was genetically confirmed with the mutation and presented with renal cell carcinoma at age 30.

      CasePresentingHPOs: HP:0009711; HP:0005584 (Retinal capillary hemangioma, Renal cell carcinoma)

      CaseHPOFreeText: The proband's brother (patient 231) had a retinal angioma at 25 and renal cell carcinoma at 54.

      CaseNotHPOs: HP:0010797; HP:0002666; HP:0001737; HP:0001732 (Hemangioblastoma, Pheochromocytoma, Pancreatic cysts, Abnormality of the pancreas)

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: This patient was also published in a later paper by Wang et al., 2018 (PMID: 29330336).

      SupplementalData: Patient and family genotype-phenotype information is listed in Supplementary Table 1.

      Variant: p.L178R (c.533T>G)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: 625261, https://www.ncbi.nlm.nih.gov/clinvar/variation/625261/

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: missense_variant;transversion

      CivicName: L178R (c.533T>G)

      MultipleGeneVariants: N/A

    2. PatientID: 239

      KindredID: 91

      Case: M, 25Y0M, Chinese

      DiseaseAssertion: VHL

      FamilyInfo: The proband (patient 239) has a sister (patient 240) who presented with multiple pancreatic cysts/tumors at 28.

      CasePresentingHPOs: HP:0010797; HP:0009711 (Hemangioblastoma, Retinal capillary hemangioma)

      CaseHPOFreeText: The proband presented with a retinal angioma at 14 and a CNS hemangioblastoma at 25.

      CaseNotHPOs: HP:0001737; HP:0001732; HP:0005584; HP:0002666 (Pancreatic cysts, Abnormality of the pancreas, Renal cell carcinoma, Pheochromocytoma)

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: This patient was also published in a later paper by Wang et al., 2018 (PMID: 29330336).

      SupplementalData: Patient and family genotype-phenotype information is listed in Supplementary Table 1.

      Variant: Exon 1 Deletion (c.1-?_340+?del)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: N/A

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: exon_loss_variant

      CivicName: Exon 1 Deletion

      MultipleGeneVariants: N/A

    1. PatientID: 7

      KindredID: 7

      Case: F, 40Y0M, Ethnicity Unknown

      DiseaseAssertion: Cerebellar Hemangioblastoma

      FamilyInfo: N/A

      CohortInfo: The cohort included a series of 20 capillary haemangioblastomas of the central nervous system for mutations of the VHL gene.

      CasePresentingHPOs: HP:0006880 (cerebellar hemangioblastoma)

      CaseHPOFreeText: N/A

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.P25L (c.74C>T)

      LegacyVariant: p.P25L (c.287C>T)

      CaseProblemVariantFreeText: N/A

      ClinVarID: 93330 https://www.ncbi.nlm.nih.gov/clinvar/variation/93330/

      CAID: N/A

      gnomAD: 0.002988 https://gnomad.broadinstitute.org/variant/3-10183605-C-T

      VariantEvidence: Refer to Table 1 for abnormal SSCP or heteroduplex patterns.

      MutationType: missense_variant;transition

      CivicName:P25L(c.74C>T)

      MultipleGeneVariants: N/A

  2. Nov 2026
    1. Of the 13 individuals tested, V:2, IV:4, IV:6, III:2, III:3, and III:11 were all found to carry the P25L mutation in the VHL gene. With the exception of family member IV:2, none of these individuals reported any features characteristic of VHL disease.

      PatientID: IV:6

      KindredID: 1

      Case: F, Age Unknown, Ethnicity Unknown

      DiseaseAssertion: Asymptomatic

      FamilyInfo: The patient had two siblings both of whom carried the P25L mutation. One was asymptomatic (IV:4) whereas another (IV:2) presented with retinal hemangioma and renal cysts. Her cousin (IV:7) was diagnosed at the age of 47 years with renal cell carcinoma and subsequently died at the age of 48 years. Her great grandmother (I:2) had died of a brain tumor in her late 50s. Her grandfather (II:3) had a brain tumor at the age of 53 years and died aged 78 years. As well, her grandfather's sister (II,1) reportedly died of stomach cancer in her 80s. Of the 13 family members tested, V:2, IV:4, IV:6, III:2, III:3, and III:11 were all found to carry the P25L mutation in the VHL gene. Refer to Figure 1 for pedigree.

      CasePresentingHPOs: N/A

      CaseHPOFreeText: N/A

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.P25L (c.74C>T)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: 93330 https://www.ncbi.nlm.nih.gov/clinvar/variation/93330/

      CAID: N/A

      gnomAD: 0.002988 https://gnomad.broadinstitute.org/variant/3-10183605-C-T

      VariantEvidence: N/A

      MutationType: missense_variant;transition

      CivicName:P25L (c.74C>T)

      MultipleGeneVariants: N/A

    2. . Of the 13 individuals tested, V:2, IV:4, IV:6, III:2, III:3, and III:11 were all found to carry the P25L mutation in the VHL gene. With the exception of family member IV:2, none of these individuals reported any features characteristic of VHL disease.

      PatientID: III:11

      KindredID: 1

      Case: F, 75, Ethnicity Unknown

      DiseaseAssertion: Asymptomatic

      FamilyInfo: The patient's father (II:3) had a brain tumour at age 53 and died at age 78. The patient's paternal aunt (II:1) died of stomach cancer at age 80. The patient's paternal grandfather died at age 50 due to a brain tumour. The patient had seven siblings, five of whom underwent genetic testing. Two were found to carry the mutation but both were asymptomatic (patient III:2 and III:3). The patient's sister (III:2) had three children all of whom carried the P25L mutation and were asymptomatic (IV:4 and IV:6) except patient IV:2 who presented with a retinal hemangioma and renal cyst. Her niece, (IV:2) had three children and one was found to carry the mutation. The patient's brother (III:3) had six children one of whom died due to clear cell renal carcinoma at age 48 but did not carry the P25L mutation (IV:7). The patient had three unaffected children who did not carry the mutation. Of the 13 family members tested, V:2, IV:4, IV:6, III:3, and III:11 were all found to carry the P25L mutation in the VHL gene. Refer to Figure 1 for pedigree.

      CasePresentingHPOs: N/A

      CaseHPOFreeText: N/A

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: Ongoing clinical follow up of the individuals with P25L over a period of 5 years has continued to show no evidence of additional clinical involvement of VHL disease.

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.P25L (c.74C>T)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: 93330 https://www.ncbi.nlm.nih.gov/clinvar/variation/93330/

      CAID: N/A

      gnomAD: 0.002988 https://gnomad.broadinstitute.org/variant/3-10183605-C-T

      VariantEvidence: N/A

      MutationType: missense_variant;transition

      CivicName:P25L (c.74C>T)

      MultipleGeneVariants: N/A

    3. Of the 13 individuals tested, V:2, IV:4, IV:6, III:2, III:3, and III:11 were all found to carry the P25L mutation in the VHL gene.

      PatientID: III:2

      KindredID: 1

      Case: F, 62, Ethnicity Unknown

      DiseaseAssertion: Asymptomatic

      FamilyInfo: The patient's father (II:3) had a brain tumour at age 53 and died at age 78. The patient's paternal aunt (II:1) died of stomach cancer at age 80. The patient's paternal grandfather died at age 50 due to a brain tumour. The patient had three children all of whom carried the P25L mutation and were asymptomatic (IV:4 and IV:6) except patient IV:2 who presented with a retinal hemangioma and renal cyst. Her daughter (IV:2) had three children and one was found to carry the mutation. The patient had seven siblings, five of whom underwent genetic testing. Two were found to carry the mutation but both were asymptomatic (patient III:3 and III:11). Patient III:3 had six children one of whom died due to clear cell renal carcinoma at age 48 but did not carry the P25L mutation. Of the 13 family members tested, V:2, IV:4, IV:6, III:3, and III:11 were all found to carry the P25L mutation in the VHL gene. Refer to Figure 1 for pedigree.

      CasePresentingHPOs: N/A

      CaseHPOFreeText: N/A

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.P25L (c.74C>T)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: 93330 https://www.ncbi.nlm.nih.gov/clinvar/variation/93330/

      CAID: N/A

      gnomAD: 0.002988 https://gnomad.broadinstitute.org/variant/3-10183605-C-T

      VariantEvidence: N/A

      MutationType: missense_variant;transition

      CivicName:P25L (c.74C>T)

      MultipleGeneVariants: N/A

    1. PatientID: 1

      KindredID: 1

      Case: M, 68Y0M, Ethnicity unknown

      DiseaseAssertion: VHL

      FamilyInfo: None.

      CasePresentingHPOs: HP:0002666; HP:0009711; HP:0000107 (pheochromocytoma, retinal capillary hemangioma, renal cyst)

      CaseHPOFreeText: Patient was found observed to have retinal angioma (retinal capillary hemangioma) and a right kidney cortex cyst (30mm). Patient's pheochromocytoma was found incidentally and he remained asymptomatic with steady weight.

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: RET, SDHB, SDHC and SDHD

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.P25L (c.74C>T)

      CaseProblemVariantFreeText: N/A

      LegacyVariant: N/A

      ClinVarID: 93330 https://www.ncbi.nlm.nih.gov/clinvar/variation/93330/

      CAID: N/A

      gnomAD: 0.002988 https://gnomad.broadinstitute.org/variant/3-10183605-C-T

      VariantEvidence: N/A

      MutationType: missense_variant;transition

      CivicName: P25L (c.74C>T)

      MultipleGeneVariants: N/A

    1. PatientID: 192

      KindredID: 73

      Case: F, 52Y0M, Chinese

      DiseaseAssertion: VHL

      FamilyInfo: The proband, patient 191, has a mother who was also found to have the same germline mutation. The proband's mother (patient 192) had a retinal angioma at 25, a CNS hemangioblastoma at 38, and multiple pancreatic cysts/tumors at 52.

      CasePresentingHPOs: HP:0010797; HP:0009711; HP:0001737; HP:0001732 (Hemangioblastoma, Retinal capillary hemangioma, Pancreatic cysts, Abnormality of the pancreas)

      CaseHPOFreeText: The patient presented with a CNS hemangioblastoma at 38, retinal angioma at 25, and multiple pancreatic cysts/tumors at 52.

      CaseNotHPOs: HP:0005584; HP:0002666 (Renal cell carcinoma, Pheochromocytoma)

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: This patient was also published in an earlier paper by Wang et al., 2014 (PMID 24581539) as well as a later paper by Wang et al., 2018 (PMID: 29330336).

      SupplementalData: Patient and family genotype-phenotype information is listed in Supplementary Table 1.

      Variant: p.R167W (c.499C>T)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: 2218; https://www.ncbi.nlm.nih.gov/clinvar/variation/2218/

      CAID: N/A

      gnomAD: 0.000007954; https://gnomad.broadinstitute.org/variant/3-10191506-C-T?dataset=gnomad_r2_1

      VariantEvidence: N/A

      MutationType: missense_variant;transition

      CivicName: R167W (c.499C>T)

      MultipleGeneVariants: N/A

    2. PatientID: 136

      KindredID: 51

      Case: M, 25Y0M, Chinese

      DiseaseAssertion: VHL

      FamilyInfo: The proband (patient 136) has a mother (patient 137) who presented with a CNS hemangioblastoma at 32, and renal cell carcinoma/ pheochromocytoma at 38. However, no DNA sample was available for his mother's genetic testing.

      CasePresentingHPOs: HP:0010797, HP:0001737, HP:0001732, HP:0005584 (Hemangioblastoma, Pancreatic cysts, Abnormality of the pancreas, Renal cell carcinoma)

      CaseHPOFreeText: The proband (patient 136) presented with multiple pancreatic cysts/tumors at 21, renal cell carcinoma at 23, and a CNS hemangioblastoma at 25.

      CaseNotHPOs: HP:0002666; HP:0009711 (Pheochromocytoma, Retinal capillary hemangioma)

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: This patient was also published in a later paper by Wang et al., 2018 (PMID: 29330336).

      SupplementalData: Patient and family genotype-phenotype information is listed in Supplementary Table 1.

      Variant: p.P146Gfs*14 (c.435_436ins)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: N/A

      CAID: CA2573131810, https://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/by_caid?caid=CA2573131810

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: plus_2_frameshift_variant

      CivicName: P146Gfs*14 (c.435_436insGG)

      MultipleGeneVariants: N/A

    1. PatientID: 2

      KindredID: 4

      Case: F, 41Y0M, Ethnicity Unknown

      DiseaseAssertion: VHL

      FamilyInfo: N/A

      CohortInfo: Thirteen patients with a supratentorial hemangioblastoma.

      CasePresentingHPOs: HP:0010797 (hemangioblastoma)

      CaseHPOFreeText: The patient had a right temporal hemangioblastoma at age 25. After surgery the patient was disease free. The patient was followed up 16 years later.

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: Exon 2-3 Deletion

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: N/A

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType:exon_loss_variant

      CivicName: Exon 2-3 Deletion

      MultipleGeneVariants: N/A

    1. The novel heterozygous nonsense amber mutation (c.555C > A) was detected in Patient D

      PatientID: 6

      KindredID: 4 (D)

      Case: M, 25Y0M, Hungarian

      DiseaseAssertion: VHL

      FamilyInfo: Patient was the only available member of the family. His father had died several years ago due to a central nervous system tumour, probably a complication of VHL disease

      CasePresentingHPOs: HP:0006880; HP:0009713; HP:0006770 (cerebellar hemangioblastoma, spinal hemangioblastoma, clear cell renal cell carcinoma)

      CaseHPOFreeText: Cerebellar and spinal cord hemangioma diagnoses.

      CaseNotHPOs: HP:0002666; HP:0009711 (pheochromocytoma, retinal capillary hemangioma)

      CaseNotHPOFreeText: No other manifestations of VHL disease were detected. See table 1.

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.Y185* (c.555C>A)

      CaseProblemVariantFreeText: N/A

      LegacyVariant: N/A

      ClinVar: N/A

      CAID: CA351756378 http://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvsOrDescriptor=NM_000551.3%3Ac.555C%3EA

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: stop_gained

      CivicName: T185* (c.555C>A)

      MultipleGeneVariants: N/A

    1. PatientID: None

      KindredID: VHL12

      Case: M, 25Y0M, Ethnicity Unknown

      DiseaseAssertion: VHL

      FamilyInfo: N/A

      CohortInfo: A total of 190 patients recruited by the COMETE network over 15 years were included in the study.

      CasePresentingHPOs: HP:0002666 (Pheochromocytoma)

      CaseHPOFreeText: The patient had two benign pheochromocytomas.

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: RET/SDHB/SDHC/SDHD

      PreviouslyPublished: N/A

      SupplementalData: Table 1 of Supplementary

      Variant: p.R161Q (c.482G>A)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: 182983, https://www.ncbi.nlm.nih.gov/clinvar/variation/182983/

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: The patient had LOH found in the BAC array CGH data.

      MutationType: missense_variant;transition

      CivicName: R161Q (c.482G>A)

      MultipleGeneVariants: N/A

    1. PatientID: N/A

      KindredID: 7

      Case: M, 58Y0M, Chinese

      DiseaseAssertion: Assumed VHL

      FamilyInfo: Patient had family history of VHL disease. Patient’s nephew presented with renal cell carcinoma at 30, patient's sister/brother presented with a hemangioblastoma at age 39 and then retinal capillary hemangioma, renal cell carcinoma, and abnormality of the pancreas at age 57. Patient’s sister presented with a hemangioblastoma at age 40. All three of these family members were genetically tested and possessed the same mutation. Patient’s other brother presented with a hemangioblastoma at age 35 but died before diagnosis and genetic testing.

      CohortInfo: 16 Chinese patients clinically diagnosed with VHL disease.

      CasePresentingHPOs: HP:0009711, HP:0005584 (retinal capillary hemangioma, renal cell carcinoma)

      CaseHPOFreeText: Patient presented with retinal hemangioma at age 25 and renal cell carcinoma at age 54.

      CaseNotHPOs: HP:0002666, HP:0030393, HP:0010797, HP:0001732 (pheochromocytoma, endolymphatic sac tumor, hemangioblastoma, abnormality of the pancreas)

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.L178R (c.533T>G)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: 625261, https://www.ncbi.nlm.nih.gov/clinvar/variation/625261/

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: missense_variant; transversion

      CivicName: L178R (c.533T>G)

      MultipleGeneVariants: N/A

    1. GroupID: 27

      Case: 45Y0M, Sex Unknown, Ethnicity Unknown

      DiseaseAssertion: assumed VHL

      FamilyInfo: 1 of the 573 patients discussed in this paper were found to have this variant. This mutation was found in 1 VHL family with a single patient.

      CasePresentingHPOs: HP:0006880; HP:0005584 (cerebellar hemangioblastoma; renal cell carcinoma)

      CaseHPOFreeText: patient had cerebellar hemangioblastoma diagnosed at 25Y, and RCC diagnosed at 45Y

      CaseNotHPOs: HP:0009711; HP:0002666 (retinal capillary hemangioma; pheochromocytoma)

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: Supplementary Table S1.

      Variant: p.Q145* (c.433C>T) 

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: 625249 https://www.ncbi.nlm.nih.gov/clinvar/variation/625249/

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: stop_gained

      CivicName: Q145* (c.433C>T) 

      MultipleGeneVariants: N/A

  3. Oct 2026
    1. DNA obtained from peripheral blood was available for all patients but only patient RCC-23, with a p.P25L alteration, showed in the germline the same aminoacidic change detected in tumor tissue.

      PatientID: RCC-23

      KindredID: 1

      Case: Sex and Age unknown, Italian

      DiseaseAssertion: VHL

      FamilyInfo: None

      CasePresentingHPOs: HP:0006770 (Clear cell renal cell carcinoma)

      CaseHPOFreeText: N/A

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.P25L (c.74C>T)

      CaseProblemVariantFreeText: N/A

      LegacyVariant: N/A

      ClinVarID: 93330 https://www.ncbi.nlm.nih.gov/clinvar/variation/93330/

      CAID: N/A

      gnomAD: 0.002988 https://gnomad.broadinstitute.org/variant/3-10183605-C-T

      VariantEvidence: N/A

      MutationType: missense_variant;transition

      CivicName: P25L (c.74C>T)

      MultipleGeneVariants: N/A

    1. PatientID: 2

      KindredID: 19

      Case: F, 33Y0M, Ethnicity Unknown

      DiseaseAssertion: VHL

      FamilyInfo: Positive. The patient's son was the proband (1) and carried the mutation but was asymptomatic. The proband's uncle (7) carried the mutation and presented with symptoms. The proband's cousin (9) and first cousin once removed (22) were also found to have the mutation but were asymptomatic.

      CohortInfo: 20 unrelated VHL families from an ethnically diverse cohort containing both affected and unaffected individuals.

      CasePresentingHPOs:HP:0010797, HP:0005584, HP:0001732, HP:0000077 (hemangioblastoma, renal cell carcinoma, abnormality of the pancreas, abnormality of the kidney)

      CaseHPOFreeText: The patient presented with a hemangioblastoma at ages 17, 24, 30. At age 25 she presented with renal cell carcinoma and abnormalities of the kidney and pancreas.

      CaseNotHPOs: HP:0009711, HP:0002666 (retinal capillary hemangioma, pheochromocytoma )

      CaseNotHPOFreeText: The patient did not have epididymal or ovarian cysts.

      CasePreviousTesting: N/A

      PreviouslyPublished: 31368132

      SupplementalData: Supplementary file 1.

      Variant: p.W88* (c.263G>A)

      LegacyVariant: p.W88* (c.476G>A)

      CaseProblemVariantFreeText: N/A

      ClinVarID: 182978 https://www.ncbi.nlm.nih.gov/clinvar/variation/182978/

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: stop_gained

      CivicName: W88* (c.263G>A)

      MultipleGeneVariants: N/A

    2. PatientID: 83 (Cousin)

      KindredID: 18

      Case: F, 50Y0M, Ethnicity Unknown

      DiseaseAssertion: VHL

      FamilyInfo: 11 members of this family tested positive for the c.712C>T/c.499C>T germline variant of the VHL gene. 14 members of this family were assumed to carry this variant due to family history/personal medical history. Members of this family range from asymptomatic to multi-organ involvement (pheochromocytoma, pancreatic and renal cysts/tumors and hemangioblastomas). The family was previously reported in PMID 3942913.

      CasePresentingHPOs: HP:0010797; HP:0009711; HP:0001732 (Hemangioblastoma, Retinal capillary hemangioma, Abnormality of the pancreas)

      CaseHPOFreeText: This patient presented with CNS hemangioblastoma (25Y), retinal angioma (16Y) and pancreatic tumors or cysts (undefined) (22Y).

      CaseNotHPOs: HP:0005584; HP:0000077; HP:0002666 (Renal cell carcinoma, Abnormality of the kidney, Pheochromocytoma)

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: 3942913 (some members of this family are previously reported (phenotypes only) but unable to match patients across papers with confidence)

      SupplementalData: Supplementary Table 1.

      Variant: p.R167W (c.499C>T)

      LegacyVariant: c.712C>T

      CaseProblemVariantFreeText: N/A

      ClinVarID: 2218, https://www.ncbi.nlm.nih.gov/clinvar/variation/2218/

      CAID: N/A

      gnomAD: 0.000007954, https://gnomad.broadinstitute.org/variant/3-10191506-C-T?dataset=gnomad_r2_1

      VariantEvidence: A point mutation (c.712C>T) was found. Being that this variant is out of bound with respect to the NM_000551.3 reference sequence, it was concluded that this variant is noted in the Latif et al. (1993) reference and was translated to c.499C>T (NM_000551.3).

      MutationType: missense_variant;transition

      CivicName: R167W (c.499C>T)

      MultipleGeneVariants: N/A

    1. PatientID: 127

      KindredID: 47

      Case: F, 28Y0M, Chinese

      DiseaseAssertion: VHL

      FamilyInfo: N/A

      CasePresentingHPOs: HP:0010797; HP:0005584; HP:0001737; HP:0001732; HP:0009711 (Hemangioblastoma, Renal cell carcinoma, Pancreatic cysts, Abnormality of the pancreas, Retinal capillary hemangioma)

      CaseHPOFreeText: The proband presented at age 25 with a CNS hemangioblastoma, retinal angioma, and renal cell carcinoma, and presented with multiple pancreatic cysts/tumors at age 28.

      CaseNotHPOs: HP:0002666 (Pheochromocytoma)

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: This kindred was also published in a later paper by Wang et al., 2018 (PMID: 29330336).

      SupplementalData: Patient and family genotype-phenotype information is listed in Supplementary Table 1.

      Variant: p.E134_V142del (c.402_428del)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: Variant listed in the paper as c.402-428delATTATTTGTGCCATCTCTCAATGTTGA, p.Glu134Aspfs*72. Listed protein change does not match deletion. Deletion is in-frame and should not lead to a frame shift. Variant updated in this annotation based on protein change listed in ClinGen/ listed on Variant Validator for c.402-428del.

      ClinVarID: N/A

      CAID: CA2573320387, https://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/by_caid?caid=CA2573320387

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: inframe_deletion

      CivicName: E134_V142del (c.402_428del)

      MultipleGeneVariants: N/A

    2. PatientID: 200

      KindredID: 77

      Case: F, 25Y0M, Chinese

      DiseaseAssertion: VHL

      FamilyInfo: The proband (patient 200) has six family members who passed away before diagnosis/ had no DNA sample available. Of the family who passed away before diagnosis: the proband's aunt 1 (patient 202) had a CNS hemangioblastoma at 27; the daughter of aunt 1 (patient 203) had a pheochromocytoma at 31; aunt 2 (patient 205) had a CNS hemangioblastoma at 43, renal cell carcinoma at 36, and multiple pancreatic cysts/tumors at 48. Of the family for whom no DNA sample was available: the proband's mother (patient 201) had a CNS hemangioblastoma at 51, multiple pancreatic cysts/tumors at 46, and a pheochromocytoma at 25; the grandson of aunt 1 (patient 204) had a pheochromocytoma at age 9; and the son of aunt 2 (patient 206) had a pheochromocytoma at 16 and renal cell carcinoma + multiple pancreatic cysts/tumors at 21.

      CasePresentingHPOs: HP:0010797 (Hemangioblastoma)

      CaseHPOFreeText: The patient presented with a pheochromocytoma and renal cell carcinoma at 36.

      CaseNotHPOs: HP:0009711; HP:0001737; HP:0001732; HP:0002666; HP:0005584 (Retinal capillary hemangioma, Pancreatic cysts, Abnormality of the pancreas, Pheochromocytoma, Renal cell carcinoma )

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: This patient was also published in a later paper by Wang et al., 2018 (PMID: 29330336).

      SupplementalData: Patient and family genotype-phenotype information is listed in Supplementary Table 1.

      Variant: p.R167W (c.499C>T)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: 2218; https://www.ncbi.nlm.nih.gov/clinvar/variation/2218/

      CAID: N/A

      gnomAD: 0.000007954; https://gnomad.broadinstitute.org/variant/3-10191506-C-T?dataset=gnomad_r2_1

      VariantEvidence: N/A

      MutationType: missense_variant;transition

      CivicName: R167W (c.499C>T)

      MultipleGeneVariants: N/A

    3. PatientID: 60

      KindredID: 23

      Case: M, 30Y0M, Chinese

      DiseaseAssertion: VHL

      FamilyInfo: The proband (patient 23) had three family members genetically confirmed with the mutation: his son/ patient 61 (asymptomatic at time of assessment), his daughter/ patient 62 (asymptomatic at time of assessment), and his cousin/ the son of his Aunt 3/ patient 68 (CNS hemangioblastoma at 26). The proband also had 5 family members who passed away before they could be confirmed with the mutation: his father/patient 63 (CNS hemangioblastoma at 35, retinal angioma at 35); his sister/ patient 64 (CNS hemangioblastoma at 24 and multiple pancreatic cysts/tumors at 31); his aunt 1/ patient 65 had a CNS hemangioblastoma at 35; his aunt 2/ patient 66 had a CNS hemangioblastoma at 20; and his aunt 3/ patient 67 had a CNS hemangioblastoma at 44.

      CasePresentingHPOs: HP:0001732; HP:0001737 HP:0010797; HP:0009711; HP:0005584 (Abnormality of the pancreas, Pancreatic cysts, Hemangioblastoma, Retinal capillary hemangioma, Renal cell carcinoma)

      CaseHPOFreeText: The proband presented with CNS hemangioblastoma and retinal angioma at 25, renal cell carcinoma and multiple pancreatic cysts/tumors at 30.

      CaseNotHPOs: HP:0002666 (Pheochromocytoma)

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: This patient was also published in a later paper by Wang et al., 2018 (PMID: 29330336).

      SupplementalData: Patient and family genotype-phenotype information is listed in Supplementary Table 1.

      Variant: p.W88S (c.263G>C)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: 2220; https://www.ncbi.nlm.nih.gov/clinvar/variation/2220/?new_evidence=true

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: missense_variant;transversion

      CivicName: W88S (c.263G>C)

      MultipleGeneVariants: N/A

    1. Methods: We performed a fundus examination and fluorescein and indocyanine green (ICG) angiography in both eyes of a young woman affected by VHL with bilateral pheochromocytoma, retinal angioma, retinal microaneurysms and unusual alterations of the deep retinal layers. A molecular analysis of the VHL gene was carried out.

      PatientID: 1 (case)

      KindredID: 1

      Case: F, 25Y0M, Ethnicity Unknown

      DiseaseAssertion: VHL

      FamilyInfo: Not significant - the paper states that the parents and siblings were negative for the mutation (indicating de novo).

      CasePresentingHPOs: HP:0002666; HP:0009711; HP:0000479; HP:0012045 (pheochromocytoma, retinal capillary hemangioma, abnormal retinal morphology, retinal flecks)

      CaseHPOFreeText: patient was referred for eye exam as part of a VHL screening program at 25Y. She has been diagnosed with bilateral pheochromocytoma at the age of 14 after an episode of acute hypertensive encephalopathy. Ophthalmoscopy disclosed in her right eye a small retinal hemangioma (1 disc diameter wide) along with feeder vessels in the mid-periphery and multiple, small, whitish, dome-shaped lesions scattered in the deeper layers of the posterior retina. Fluorescein and indocyanine green angiography confirmed the presence of the retinal hemangioma; multiple window-defects were also seen at the posterior pole and pericentral retina and hypofluorescent dots. (Unusual alterations of the deep retinal layers).

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.T157I (c.470C>T)

      LegacyVariant: p.T157I (c.683C>T)

      CaseProblemVariantFreeText: N/A

      ClinVarID: 223223 https://www.ncbi.nlm.nih.gov/clinvar/variation/223223/

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: missense_variant;transition

      CivicName: T157I (c.470C>T)

      MultipleGeneVariants: N/A

    1. 709 G-->T transversion present in all affected subjects and in four presymptomatic children.

      PatientID: II:7

      KindredID: 1

      Case: M, Age Unknown, Jewish

      DiseaseAssertion: VHL

      FamilyInfo: This kindred of Jewish-Kurdish origin consisted of 3 generations of 25 members. 7 were clinically affected subjects with pheochromocytoma (5 of which had the confirmed mutation - I:1, II:2, II:4, II:7 and II:9, as the other 2, II:5 and II:10 were said to have passed due to complications of the disease - prior to any genetic testing), and 4 others were carriers, or pre-symptomatic (III:1, III:3, III:7 and III:12). Subject 11:7 developed a cerebellar hemangioblastoma 25 yr after his initial diagnosis of pheochromocytoma, leading to the clinical diagnosis of VHL in the kindred.

      CasePresentingHPOs: HP:0002666; HP:0006880; HP:0030074 (pheochromocytoma, cerebellar hemangiolastoma, chemodectoma)

      CaseHPOFreeText: patient had cerebellar HB at 25Y, after his initial diagnosis with bilateral pheochromocytoma, and then also extra-adrenal chromafin tumors (carotid body chemodectoma).

      CaseNotHPOs: HP:0005584 (renal cell carcinoma)

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: 33471715

      SupplementalData: N/A

      Variant: p.V166F (c.496G>T)

      LegacyVariant: p.V166F (c.709G>T)

      CaseProblemVariantFreeText: N/A

      ClinVarID: 2224, https://www.ncbi.nlm.nih.gov/clinvar/variation/2224/

      CAID: N/A

      VariantEvidence: N/A

      VariantEvidence: N/A

      MutationType: missense_variant;transversion

      CivicName: V166F (c.496G>T)

      MultipleGeneVariants: N/A

    1. Complete deletion

      GroupID/ KindredID: 28

      PatientID: I

      Case: 27Y0M, Sex unknown, Polish

      DiseaseAssertion: VHL

      FamilyInfo: Family 28 consisted of 4 members; one relative (age 24Y) diagnosed with a single cerebellar HAB, another (40Y) diagnosed at 30Y with multiple cerebellar HABs, and multiple spinal HABs, and a final relative (62Y), diagnosed with a single HAB.

      CasePresentingHPOs: HP:0009713; HP:0006880 (spinal hemangioblastoma, cerebellar hemangioblastoma)

      CaseHPOFreeText: Patient was found with multiple cerebellar HABs at 25Y, and multiple spinal HABs

      GroupNotHPOs: HP:0009711; HP:0005584 (retinal capillary hemangioma; renal cell carcinoma)

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: complete deletion of VHL gene

      CaseProblemVariantFreeText: N/A

      LegacyVariant: N/A

      ClinVarID: N/A

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: Haplotype analysis information in Table 3

      MutationType: deletion

      CivicName: deletion

      MultipleGeneVariants: N/A

    1. c.263G > C p.Trp88Ser

      GroupID: 6B

      DiseaseAssertion: assumed VHL

      GroupSize: 9

      GroupNumberMales: N/A

      GroupNumberFemales: N/A

      GroupEthnicity: Chinese

      GroupAgeRange: 33.8Y +/- 17.6Y

      GroupInfo: Clinical characteristics of 258 patients from 80 unrelated Chinese families were reported in this study. Grouped by the 21 mutations found, 3 families with 13 members total were described. it is unclear how many distinct families are reported in group 6B. 9 individuals were described. Phenotypic information was given for this mutation.

      GroupPresentingHPOs: HP:0010797; HP:0009711; HP:0005584; HP:0001737; HP:0009715 (hemangioblastoma, retinal capillary hemangioma, renal cell carcinoma, pancreatic cysts, papillary cystadenoma of the epididymis)

      GroupHPOFreeText: 7 of the 9 members presented with CNS hemangioblastoma (mean age of 29.9Y), 2/9 had retinal angiomas at 25Y and 35Y, 1 had renal cell carcinoma (at 30Y), pancreatic cysts in 2 members (with an age of onset of 30 and 31Y), and 1 member with a genital system tumor (epididymis or broad ligament) at 24Y

      GroupNotHPOs: HP:0002666 (pheochromocytoma)

      GroupNotHPOFreeText: No patients were given with pheochromocytoma

      GroupPreviousTesting: N/A

      PreviouslyPublished: 29330336; 28388566

      SupplementalData: N/A

      Variant: p.W88S (c.263G>C)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: 2220, https://www.ncbi.nlm.nih.gov/clinvar/variation/2220/

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: missense_variant;transversion

      CivicName: W88S (c.263G>C)

      MultipleGeneVariants: N/A

    1. Case presentationA 35-year-old woman with VHL underwent total pancreatectomy and right nephrectomy for pancreatic SCN and renal cell carcinoma, respectively. At the 4th year follow-up examination after the resection, contrast-enhanced computed tomography (CT) and gadolinium ethoxybenzyl diethylenetriamine penta-acetic acid (Gd-EOB-DTPA)-enhanced magnetic resonance imaging (MRI) showed arterially hyper-enhanced neoplastic lesions in the segment VI and VIII of the liver. Partial resections of the liver were performed 53 months after the initial surgery. At the 6th month follow-up examination from the second surgery, one and two tumors located in the liver segment III, and VIII, respectively, were detected by contrast-enhanced CT and Gd-EOB-DTPA-enhanced MRI. Anterior segmentectomy and partial resection of the segment III were performed 66 months after the initial surgery and 13 months after the second, respectively. The tumors were pathologically diagnosed as liver metastases of pancreatic SCN synonymous with serous cystadenocarcinoma. She remains disease-free without recurrence 6.5 years after the last operation.

      PatientID: 1

      KindredID: 1

      Case: F, 47Y0M, Ethnicity Unknown

      DiseaseAssertion: VHL

      FamilyInfo: No family history.

      CasePresentingHPOs: HP:0006880; HP:0002894; HP:0005584 (Cerebellar Hemangioblastoma; neoplasm of the pancreas; renal cell carcinoma)

      CaseHPOFreeText: At 35-year old, the female patient was diagnosed with VHL due to clinical presentation of pancreatic serous cystic neoplasm and renal cell carcinoma, and cerebellar hemangioblastomas that were surgically removed at age 21. The patient had underwent total pancreatectomy and right nephrectomy for pancreatic serous cystic neoplasm (SCN) and renal cell carcinoma (RCC), respectively. 4 years later, tumors in the liver were detected by CT scan and radiographically diagnosed as metasta-ses of the pancreatic SCN or RCC. Again, morphology and immunohistochemical findings of the resected tumors again were similar to the primary pancreatic SCN, thus diagnosed as multiple metachronous liver metastases of pancreatic SCN. As of 47Y, the patient has remained disease-free without any recurrence after the third operation.

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: 21673464

      SupplementalData: N/A

      Variant: p.N78I (c.233A>T)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: 223169 https://www.ncbi.nlm.nih.gov/clinvar/variation/223169/

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: missense_variant;transition

      CivicName: N78I (c.233A>T)

      MultipleGeneVariants: N/A

    1. 10PCCF25+VHL60/40Multiple−− VHL 3Germlinec.499C>Tp.Arg167TrpPathogenic

      PatientID: 10

      KindredID: 2

      Case: F, 25Y0M, Ethnicity Unknown

      DiseaseAssertion: VHL

      FamilyInfo: Patient has 2 siblings (patients 11 and 12) with the same mutation and pheochromocytoma.

      CasePresentingHPOs: HP:0002666 (Pheochromocytoma)

      CaseHPOFreeText: Bilateral pheochromocytomas (60mm and 40mm)

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: SDHB (NM_003000.2), SDHC (NM_003001.3), SDHD (NM_003002.2), SDHAF2 (NM_017841.2), RET (exons 10–11 and 13–16, NM_020975.4), TMEM127 (NM_017849.3), MAX (NM_002382.3).

      PreviouslyPublished: N/A

      SupplementalData: Table 2

      Variant: p.R167W (c.499C>T)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: 2218, https://www.ncbi.nlm.nih.gov/clinvar/variation/2218/

      CAID: N/A

      gnomAD: 0.000007954, https://gnomad.broadinstitute.org/variant/3-10191506-C-T

      VariantEvidence: SNParray analysis of tumour DNA did not show LOH at any locus.

      MutationType: missense_variant;transition

      CivicName: R167W (c.499C>T)

      MultipleGeneVariants: N/A

    1. VHL_2Frozenc.250G>Tp.Val84LeuM25AdrenalPCCB

      PatientID: VHL_2 (tumor ID)

      KindredID: 2

      Case: M, 25Y0M, Ethnicity Unknown

      DiseaseAssertion: Adrenal pheochromocytoma

      FamilyInfo: N/A

      CasePresentingHPOs: HP:0006748 (Adrenal pheochromocytoma)

      CaseHPOFreeText: The patient had a benign adrenal pheochromocytoma at 25Y.

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.V84L (c.250G>T)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: 2236, https://www.ncbi.nlm.nih.gov/clinvar/variation/2236/

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: missense_variant;transversion

      CivicName: V84L (c.250G>T)

      MultipleGeneVariants: N/A

  4. Sep 2026
  5. May 2026
    1. sycophancy rate of around 25% in relationship conversations

      【洞察】在关系类对话中,Claude 的迎合率高达 25%——四分之一的回答在「讨好」用户而非提供真实建议。这是 AI 对齐最隐蔽的失效形式:模型没有产生任何有害内容,却系统性地强化了用户可能错误的决策。Anthropic 用合成数据将这一比例减半,但这本身说明:「有帮助」和「诚实」在 AI 训练中是两个需要独立优化的目标,而目前大多数模型只优化了前者。

  6. Apr 2026
  7. Feb 2026
  8. Dec 2025
    1. Klaus Taschwe im Standard zur Arbeit des Hartland Instituts punkt das Institut hat jetzt in London eine Diplonore aufgemacht. Komma die von einer früheren Vorsitzenden der Antibrexipathal-Yukip geleitet wird. Es versucht in enger Kooperation mit der FPÖ den Europien Drain Deal abzusprechen bzw. zu blockieren. Das Institut gehört zum Aufdraggebern des sogenannten Project 2025-Kommar, dem Drehbuch für das Vorgehen der Tram-Administration gegen bisherige Regierungsinstitutionen vor allem In Bereichen wie Wissenschaft und Diversität https://www.derstandard.at/story/3000000254264/us-lobby-der-klimawandelleugner-dank-fpoe-weiter-auf-dem-vormarsch-in-europa

  9. Nov 2025
  10. drive.google.com drive.google.com
    1. She knew this coffee-drinking guy wanted tohave sex with her, and she was considering it, but he wasn't improv-ing his chances by making her feel stupid.

      he uses knowledge to make her feel inferior, rather than treating her as an equal.

    2. Maybehe deserved her contempt, but Corliss realized that very few youngmen read poetry at Washington State University.

      I’m surprised that even though she dislikes him, she still respects that he reads poetry, which changes how she sees him.

    3. Yes. So I started crying, and I kept crying, and I couldn't stop cry,ing no matter how hard I tried. They tell me I cried for two weeksstraight, but all I remember is that first day. I took a leave of absencefrom school, sold my house, and spent my money in a year, and nowI'm here, relying, as they say, on the kindness of strangers.''"I am kind because you are kind. Thank you for sharing your story.'

      She has the thoughts that she wants to give up but has the world is holding her.

    4. She sat at a Mac and logged on.Her user name was "CrazyIndian," and her password was "StillCrazy."

      Though this sentence is a little bit related to the book title, why her username is CrazyIndian? Is it indicates the scene, or is it a simple meaning?

    5. I kept shouting, 'I want some respect! I want some respect!' Ishouted it all day and all night. And nobody gave me any respect. Iwas asking directly for it, and people just kept walking around me.Avoiding me. Not even looking at me. Not even acknowledging m

      He keep asking for respect, but nobody listens to him. People ignore him and act like he doesn’t exist, which shows how lonely and powerless he feels.

    6. Corliss couldn't help herself. She loved her mother, but her motherwas a bipolar storyteller who told lies during her manic phases andheavily exaggerated during her depressed times. Those lies and ex~aggerations were often flattering to Corliss, so it was hard to com~pletely resent them

      Corliss loves her mother, but her mother often tells lies or exaggerates because of her bipolar disorder. Since these stories usually make Corliss look good, she can’t really hate them.

    7. Corliss had never once considered the fate of library books. She'dnever wondered how many books go unread. She loved books. Howcould she not worry about the unread? She felt like a disorganizedscholar, an inconsiderate lover, an abusive mother, and a cowardlysolider

      Corliss suddenly feels guilty when she realizes she has never thought about the forgotten books in the library.

    8. For her, each great book was

      This sentence illustrates how Corliss elevates literature to a near-religious status. It reveals her tendency to surrender critical judgment when she admires a writer. It also shows how her passion for reading can blur into blind devotion.

    9. I think you're going to find I'm writing themost authentic Indian poems that have ever been written

      This sentence shows how highly Harlan values his own work. It suggests a desire to prove his cultural legitimacy. It also hints that his idea of authenticity may be shaped more by ego than community tradition.

    10. We're still Indian.

      This passage is interesting because Corliss feels a deep emotional connection to the poet simply because she has shared the same physical landscape. The moment she calls her mother brings the scene back to everyday reality and contrasts her idealistic excitement with her mother’s practical view of identity.

    1. new definition, which defines a city as a contiguous geographic area with at least 50,000 inhabitants at an average population density of 1,500 people per square kilometer

      for - definition - city - a geographic area with - at least 50,000 inhabitants - an average population density of 1,500 people/square kilometer - stats - 25% of people live in towns - 48 % of people live in cities - 25% of people live in villages - towns and cities

      • according to this new definition, which standardizes the definition of city that has, hitherto been quite varied, 48% of humanity lives in cities (2015)
  11. Sep 2025
  12. Aug 2025
    1. Portable Typewriters Today - February 2015<br /> by [[Will Davis]] on 2015-02-10<br /> accessed on 2025-08-05T16:35:48

  13. Jul 2025
    1. Mister Rogers arrives with a card showing the word "typewriter" on one side and a picture of a typewriter on the other. In the kitchen, he has a real typewriter set up which he demonstrates for viewers. Mister Rogers talks about mothers and fathers who use typewriters before he sings I'd like to Be Just Like Mom and Dad. As he sings, a short film is shown about mothers and fathers.

      https://www.neighborhoodarchive.com/mrn/episodes/1083/index.html

  14. Jun 2025
  15. May 2025
    1. Im ersten Quartal 2025 übertraf die installierte Kapazität von Wind- und Solarenergie in China erstmals die von Kohlekraftwerken, mit 1,482 Milliarden Kilowatt gegenüber 1,451 Milliarden Kilowatt. China hat 2024 weltweit 357 Gigawatt neue erneuerbare Energien installiert, zehnmal mehr als die USA. Bis 2030 plant China, 1.200 Gigawatt erneuerbare Energien zu installieren, um bis 2060 klimaneutral zu werden.

      [Zusammenfassung mit Mistral generiert]

      https://www.repubblica.it/economia/2025/04/25/news/cina_rinnovabili_trump_carbone_energia_terre_rare-424148525/

  16. Mar 2025
    1. In Ihrem Global Energy Review 2025 steht die EAA einen re Commissionen zuwachs im Verbrauch und Produktion von Elektrozytet fest. Dieser Zufachs geht allerdings nur in ganz kleinen Teilen auf den Ersatzforsilerenergien zurück und ist im Wesentlichen durch zunehmenden Energieverbrauch bedingt, z.B. durch Datencenter. Durch diesen Zuwachs steigt der Verbrauch, steigt der Bedarf an bestimmten Mitte um Mineralien ebenfalls sprunghaft an. Der Chef der Ehea geht davon aus, dass um 20-30 Gruppen verknab werden wird. Der Kommentar der Tat weiß deshalb darauf hin, dass die Dekabonisierung durch den Umstieg auf erneuerbare Energien ohne Reduzierung des Verbrauchs nicht gelingen wird. https://taz.de/Die-Tuecken-der-Energiewende/!6074719/

  17. southtexascollege.blackboard.com southtexascollege.blackboard.com
    1. Yet thou triumph’st, and say'st that thou <br /> Find’st not thy self, nor me the weaker now;

      In line 26, the listener explains how they feel no guilt, and there is no consequence from taking the flea's life as it took both their blood.

  18. Feb 2025
  19. Jan 2025
  20. Dec 2024
  21. Nov 2024
  22. Oct 2024
  23. Sep 2024
    1. safe boundary of at least 20–25% of natural or semi-natural habitat per km2 in human-modified lands (ie, urban and agro-ecosystems) is needed to support both Earth-system NCP and local NCP, in addition to the functions provided by largely intact lands.

      for - stats - earth system boundary - biodiversity - human modified ecosystems - minimum of 20 to 25% natural / semi-natural habitat per square kilometer

    1. The loss of the tail is inferred to have occurred around 25 million years ago when the hominoid lineage diverged from the ancient Old World monkeys (Fig. 1a), leaving only 3–5 caudal vertebrae to form the coccyx, or tailbone, in modern humans14.

      for - human evolution - loss of tail approximately 25 million years ago - identified genomic mechanism leading to loss of tail and human bipedalism - human ancestors - up to 60 Ma years ago

  24. Aug 2024
  25. Jul 2024
    1. for - social tipping point - 2023 paper - paper details

      paper details - title: The Pareto effect in tipping social networks: from minority to majority - author - Jordan Everall - Jonathan. F Donges - Ilona. M. Otto - Preprint date - 20 Nov 2023 - Publication - EGUsphere Preprint Repository

      summary - This is a recent 2023 paper that summarizes social tipping point research for fields of interest to me, such as climate change. - I'm reading, looking for any real world experimental validation of social tipping point in climate change - I didn't find any but still interesting

      from - search - google - research on complex contagion refutes the 25% social tipping point threshold - https://www.google.com/search?q=research+on+complex+contagion+refutes+the+25%25+social+tipping+point+threshold&oq=research+on+complex+contagion+refutes+the+25%25+social+tipping+point+threshold&gs_lcrp=EgZjaHJvbWUyBggAEEUYOTIGCAEQRRhA0gEJMjAyOTRqMGo3qAIAsAIA&sourceid=chrome&ie=UTF-8 - search results returned of interest - The Pareto effect in tipping social networks: from minority to ... - https://egusphere.copernicus.org/preprints/2023/egusphere-2023-2241/

    1. for - social tipping points - Centola 25% threshold - critique - to - Medium - Overselling the Science of Tipping Points

      comment - The author raises valid critique of Centola's 25% threshold. - His main critique concerns the experiment not representing real world complex scenarios and is summarized in 3 points: - The experimental method used is an oversimplification of the complexity of real world complex issues such as climate change denial and meat eating, which are deeply ingrained beliefs in many cases. - No such attachment exists in the experimental setup - In the experiment, the subjects were incentified. In complex real world issues, there is often no incentive structure - Real life isn't all 1-1 interactions

      to - Medium - Overselling the Science of Tipping Points - https://hyp.is/Aocs0D7WEe-knadNGOYVog/prlicari.medium.com/overselling-the-science-of-social-tipping-points-16095145d32

  26. May 2024
    1. Der französische Präsident Macron hat in einer "Rede zur ökologischen Planung" dargestellt, wie Frankreich bis 2030 138 Millionen Tonnen CO2-Emissionen einsparen soll. Einige der Maßnahmen, z.b Förderung der Telearbeit Carsharing und Unterstützung des Leasing von Elektroautos, sind entschiedener als in vielen anderen Staaten. Insgesamt schätzen Fachleute die Maßnahmen aber als zu vorsichtig und zum Teil sogar als Verwässerung früher angekündigter Schritte ein. https://www.liberation.fr/politique/en-direct-suivez-le-conseil-de-planification-ecologique-et-le-discours-demmanuel-macron-20230925_R24KBBQHMFBNJDH2457O7LDNMU/

      Text und Video der Rede: https://www.elysee.fr/emmanuel-macron/2023/09/25/conseil-de-planification-ecologique

  27. Apr 2024
  28. Mar 2024
    1. 6:15 "born this way" versus "soziales konstrukt" ... nature versus nurture.<br /> siehe auch: calhoun experiments on overpopulation, universe 25, 1958<br /> bei übervölkerung sieht man in städten (in zentren) "dekadenz" und "sittenverfall" ...<br /> also aggression, homosexualität, kaputte familien (mütter lassen ihre kinder verhungern), ...<br /> und am rand der städte sieht man "the beautiful ones" (aussteiger, einsiedler, einzelgänger)<br /> die komplett alleine bleiben, und den ganzen tag ihr fell pflegen.<br /> (die beautiful ones sind die führer, avantgarde, pioniere, ... die einen neuen lebensraum suchen wollen,<br /> aber die am rand vom mauskäfig blockiert werden)

  29. Feb 2024
    1. Besprechung des illustrierten Buchs Wilding: How to Bring Wildlife Back – An Illustrated Guide über das Rewilding einer ehemaligen Milchproduktions-Farm in England durch Isabella Tree und ihnen Mann. Ein Ergebnis ist, dass der in Ruhe gelassene Boden nach etwa 20 Jahren allein so viel CO2 aufnimmt wie es sonst gepflanzte Bäume tun würden. https://www.theguardian.com/environment/2024/feb/25/rewilding-climate-change-biodiversity-isabella-tree-nature-planet-farming

  30. Jan 2024
  31. Dec 2023
      • for: system justification theory, status quo bias

      • summary

        • Supporting their hypotheses, the authors identify a general trend that social marginalization is associated with less system-justification.
        • Those benefitting from the status quo (e.g., healthier, wealthier, less lonely) were more likely to hold system-justifying beliefs.
        • However, some groups who are disadvantaged within the existing system reported higher system-justification—suggesting that
          • system oppression may be a key moderator of the effect of social position on system justification.
        • This is a very important finding and could be used to develop more effective social tipping point strategies
  32. Nov 2023
    1. Die Menschheit bewegt sich auf mehrere "Risiko-Kipppunkte" zu. Wenn sie überschritten werden, sinkt die Fähigkeit, Unglücke zu überstehen, erheblich. In einer Studie der UN University (mit Sitz in Deutschland) werden sechs dieser Punkte untersucht, etwa der Punkt, an dem sich Gebäude nicht mehr versichern lassen. Diese ökologisch-sozialen Schwellenwerte unterscheiden sich von den durch verstärkendes Feedback charakterisierten Kipppunkten im Sinn der Erdsystem-Wissenschaften. https://www.theguardian.com/environment/2023/oct/25/climate-crisis-threatens-tipping-point-of-uninsurable-homes-says-un

      Studie: https://interconnectedrisks.org/

      Mehr zum 2023 Interconnected Disaster Risks Report: Studie: https://interconnectedrisks.org/

  33. Oct 2023
    1. Der deutsche Wirtschafts- und Klimaschutzminister Robert Habeck hat ein im Bundeskabinett nicht abgestimmtes Papier zur Industriestrategie vorgelegt. Zur Stärkung des Industriestandorts Deutschland soll die Wirtschaft um 50 Milliarden Euro entlastet werden. Der Strompreis soll subventioniert werden. Außerdem will Habeck die Abscheidung und Speicherung von CO2 in Deutschland ermöglichen. https://taz.de/Deutsche-Industriepolitik/!5965372/

    1. https://en.wikipedia.org/wiki/Shmita

      During shmita, the land is left to lie fallow and all agricultural activity, including plowing, planting, pruning and harvesting, is forbidden by halakha (Jewish law).

      The sabbath year (shmita; Hebrew: שמיטה, literally "release"), also called the sabbatical year or shǝvi'it (שביעית‎, literally "seventh"), or "Sabbath of The Land", is the seventh year of the seven-year agricultural cycle mandated by the Torah in the Land of Israel and is observed in Judaism.

    1. Water immobilization is a cool thing! The simplest way to accomplish it is by freezing. But can you think of how water might be immobilized (so to speak) at temperatures above freezing, say at 50°F (10°C)? Think Jell-O and a new process that mimics caviar and you have two methods that nearly stop water in its tracks.

      I learned that science and cooking is always connected. Even if we don't think about it in every day life like when water evaporates or freezes it is chemistry. But what I found most interesting that I learned is how water immobilization works, or to put it more simply the science behind Jell-O. When you add gelatin to water it traps the water molecules in place which creates the sort of liquid and solid hybrid we find with Jell-O.

  34. Aug 2023
    1. Without a solid spiritual foundation, humanity may well continue on its path toward self-destruction, whether it be through environmental collapse, nuclear war or Artificial Intelligence gone haywire. On the other hand, if we evolve our culture to value inner work as much as we value outer work, then our individual and collective spiritual wisdom might just catch up with our rapidly advancing technology.
  35. Jul 2023
  36. Jun 2023
  37. May 2023
  38. Feb 2023
    1. Le chef d'établissement fixe l'ordre du jour, les dates et heures des séances du conseil d'administration en tenant compte, au titre des questions diverses, des demandes d'inscription que lui ont adressées les membres du conseil. Il envoie les convocations, accompagnées de l'ordre du jour et des documents préparatoires, au moins huit jours à l'avance, ce délai pouvant être réduit à un jour en cas d'urgence.
    1. real-life situations can be much more complicated, the authors’ model allows for the exact 25 percent tipping point number to change based on circumstances. Memory length is a key variable, and relates to how entrenched a belief or behavior is.
      • 25% social tipping point threshold is adjustable
      • depending on the variables of the context
      • = question - how do we apply this adjustability for complex contagion such as climate change norms?
    2. When a minority group pushing change was below 25 percent of the total group, its efforts failed. But when the committed minority reached 25 percent, there was an abrupt change in the group dynamic, and quickly a majority of the population adopted the new norm.
      • = 25% Social Tipping Point
      • A committed minority group pushing for change just below 25% of the total group population does not succeed
      • but when the committed minority is just above 25%,
      • abrupt change in group dynamics quickly causes a majority of the population to adopt the new norm
  39. Nov 2022
  40. Jun 2022
  41. www.intendance03.fr www.intendance03.fr
    1. Que se passe t’il si l’ordre du jour du CA n’est pas voté ? Lorsque le conseil d’administration se réunit en séance ordinaire, un projet d’ordre du jour est adressé par le chef d’établissement aux membres en même temps que leur convocation. L’ordre du jour doit ensuite être adopté en début de séance à la majorité des suffrages exprimés (art. R. 421-25 du code de l’éducation). Les membres peuvent donc refuser d’adopter le projet d’ordre du jour proposé par le chef d’établissement. Dans cette hypothèse, il n’est pas possible de poursuivre la séance qui devrait être levée. En effet,dès lors qu’un point n’est pas inscrit à l’ordre du jour de la séance, il ne peut valablement être soumis au vote durant cette séance. Cependant, afin d’éviter un blocage, il peut être envisagé de voter point par point les différents éléments du projet d’ordre du jour, car si un seul point est contesté par la majorité des membres du conseil d’administration, les autres points pourront ainsi être adoptés, discutés puis soumis au vote lors de la séance.  
  42. Feb 2022
    1. decision draws its legitimacy from the Supreme Court’s interpretation of Article 25(1) (all persons areequally entitled to freedom of conscienceand the right freely to profess, practise and propagate religion) to the effect that “essential practices” of religions are protected from restrictions imposed by the state except to uphold “public order, morality and health”.
  43. Jan 2022
  44. Dec 2021
  45. Nov 2021
    1. Social convention, which has for so long worked against us, can if flipped become our greatest source of power, normalising what now seems radical and weird. If we can simultaneously trigger a cascading regime shift in both technology and politics, we might stand a chance. It sounds like a wild hope. But we have no choice. Our survival depends on raising the scale of civil disobedience until we build the greatest mass movement in history, mobilising the 25% who can flip the system.

      This is the core philosophy behind Stop Reset Go, but NOT NECESSARILY just in the direction of civil disobedience. To invest only in that is to put all our eggs in one basket that top down actors will be pressured beyond a certain threshold. It may happen, it may not, or it may just take too long. We must diversify and also invest in systematized bottom-up efforts.

  46. Jul 2021
  47. Jun 2021
  48. May 2021
  49. Mar 2021
    1. Results for individual PALB2 variants were normalized relative to WT-PALB2 and the p.Tyr551ter (p.Y551X) truncating variant on a 1:5 scale with the fold change in GFP-positive cells for WT set at 5.0 and fold change GFP-positive cells for p.Y551X set at 1.0. The p.L24S (c.71T>C), p.L35P (c.104T>C), p.I944N (c.2831T>A), and p.L1070P (c.3209T>C) variants and all protein-truncating frame-shift and deletion variants tested were deficient in HDR activity, with normalized fold change <2.0 (approximately 40% activity) (Fig. 1a).

      AssayResult: 6.9

      AssayResultAssertion: Normal

      StandardErrorMean: 0.35

    1. Most Suspected Brugada Syndrome Variants Had (Partial) Loss of Function

      AssayResult: 2.9

      AssayResultAssertion: Abnormal

      ReplicateCount: 20

      StandardErrorMean: 2.1

      Comment: This variant had loss of function of peak current (<10% of wildtype), therefore it was considered abnormal (in vitro features consistent with Brugada Syndrome Type 1). (Personal communication: A. Glazer)

  50. Feb 2021
  51. Sep 2020
  52. Jun 2019
  53. May 2019
    1. First strand synthesis of mRNA into eDNA was performed using First strand eDNA synthesis kit from Invitrogen following manufacturer's protocol. Briefly, 4 jlg of total RNA was denatured at 65°C for 5 min in the presence of Oligo dT 16 and dNTPs and incubated at 42°C for another 2 min with DTT, MgCb, and RNaseOUT in 10 X reverse transcription buffer. 1 IlL/reaction of the Superscript Reverse Transcriptase enzyme was added to the denatured RNA and incubated at 42°C for 50 min. The enzyme was denatured by heating at 70°C for 15 min. The reaction was completed by a quick high-speed centrifugation and the complementary RNA strand degraded by incubating with RNaseH for 20 min at 37°C. The preparation was stored at -70°C.
    1. For construction of desired clones, 1-2 μg of DNA was used for restriction digestion. In a typical reaction, 2-5units of restrictionenzymeswereused in the total reaction volume of 50μl along with5μl ofrecommended buffer (supplied as 10X digestion buffer). The reaction mixture was incubated for 3-5 hat 37oC. The digested DNAwasthenloaded along with DNA size marker and separated on agarose gel electrophoresis. The gel was visualized over a UV illuminator and section containing the desired DNA fragment was carefully sliced out. The sliced agarose gel was then processed using commercially available Gel Extraction kit (Qiagens) for this purpose
    1. On the HPLC system (Waters Empower Software), the instrument method was set to the programme ‘tritium small coloumn’ and the method set was set to ‘tritium small column’. The ‘set up’ icon was selected and once the flow rate was 1 mL/min, the ‘prepare’ icon was selected. A gradient was generated by mixing buffer A and bufferB as described below (Section 2.1.6.6). The injector was moved to the load position and sample was injected using a 1 mL syringe. The injector was moved to the inject position and the ‘inject’ icon was pressed immediately. On the fraction collector, the ‘run’ button was pressed immediately. The syringe was rinsed 5 times with buffer A
    2. HPLC set upA strong anion exchange partisphere SAX 4.6 mm diameter and 125 mm length column (Whatman) was fixed to the HPLC system (Waters 515 pumps). The column was equilibrated with buffer A (1 mM EDTA) (Section 2.1.6.6) overnight at 100 μL/min flow rate.Before starting the HPLC run, the fraction collector (BioRad 2110) was prepared by placing the outlet tube to vial 1 on the fraction collector. Fresh FACS tubes were placed at fraction numbers 40-65 on the fraction collector. The flow rate on the fractioncollector was set to 1 mL/min and it was kept ready.The SAX column was allowed to equilibrate (warmup programme) with Buffer A by slowly increasing theflow rate from 0.1 to 1 mL/min over a period of 70 min
  54. Nov 2018
  55. Sep 2018
    1. he will see that the first nominations are to be made by the existing governments. Thus the Government of Canada, that of New Brunswick and that of Nova Scotia will appoint legislative councillors, but afterwards the Federal Government will make the appointments. The honorable member for Quebec can, with reason, draw the conclusion that there is no guarantee that the views of the provinces will be respected. I for my part have investigated the matter, more in connection with the power that will be vested in the legislative councillors. I asserted that by appointing them for life and limiting their number, an absolute authority would be created, which would be quite beyond the control of the people and even of the Executive; that the power of this body will be so great, that they will always be in a position to prevent every reform if they thought proper, and that a collision between the two branches would be inevitable and irremediable. The danger arising from the creating of such a power is exactly that of being obliged to destroy it if they resist too obstinately the popular demands. In England there is no necessity for breaking down the obstructions sometimes presented by the House of Lords, because the Crown having it in its power to appoint new peers, can overcome the difficulty. Here there will be no means of doing it, when the number of councillors is fixed. Accordingly, I have looked at the question through the medium of the powers assigned to the councillors, whereas the honorable member for the county of Quebec fears lest the Government should make choice of men who would not represent public opinion in the provinces; that they might appoint members all of French origin or all of English origin to represent Lower Canada, or take them all from among

      §§.24, 25, 26, and 28 of the Constitution Act, 1867. of the Constitution Act, 1867.

    2. In our Constitution it is the duty of the Legislative Council to exercise the conservative influence, and to modify the legislation too energetic and too full of outside effervescence, which is sent for their consideration from the House of Commons. But when public opinion gains vigor from the obstacles which it encounters, and the reforms demanded are rational and come before them in due course, there is no danger that the legislation which embodies them will be obstructed in its progress; for the people will rise in their majesty and in their sense of justice, as did the people of England in 1832, and the obstacles they might meet with on their way would be swept away as by a torrent. (Hear, hear.) HON. MR. DORION—That is exactly where the danger lies. HON. MR. CAUCHON—That is the danger which assailed the House of Lords in 1832, but no one would venture to confront to the last extremity a danger such as this. But the honorable member for Quebec tells us, if I understand him rightly, that we have not sufficient guarantees for Lower Canada in the appointment of the legislative councillors. The selection of legislative councillors has no bearing whatever on the question we are now considering, viz., whether the appointment by the Crown is or is not preferable to the elective principle. But in answer to him I will say, that the scheme before us seems to be quite clear. According to this plan the candidates for the Legislative Council will be recommended by the local governments and appointed by the General Government, and it is by this very division of powers that the selections are sure to be good, and made in conformity with the desire and sentiments of the provinces. HON. MR. DORION—Only the first nominations are to be made in this manner, not those which may be made afterwards. HON. MR. CAUCHON—The first nominations will be made by the present Governments, and the federal councillors will be taken from the present legislative councillors to the number prescribed, 24, provided so many can be found who will accept the post, and who possess the requisite property qualification. The Conference has engaged, by the terms of the scheme, to respect the rights of the Opposition, and any government who should fail to carry out so solemn an engagement would well deserve to lose the public confidence. (Hear, hear.) I repeat that the mode of appointing the councillors in no wise affects the conservative principle of nomination on which the constitution of the Legislative Council ought to be based.

      §§.24, 25, 26, and 28 of the Constitution Act, 1867. of the Constitution Act, 1867.

    1. In order to protect local interests, and to prevent sectional jealousies, it was found requisite that the three great divisions into which British North America is separated, should be represented in the Upper House on the principle of equality. There are three great sections, having different interests, in this proposed Confederation.

      §§. 21-36 & § 91(1) of the Constitution Act, 1867

      Referenced in Re: Authority of Parliament in relation to the Upper House, [1980] 1 SCR 54, 1979 CanLII 169 (SCC)

    2. To the Upper House is to be confided the protection of sectional interests ; therefore is it that the three great divisions are there equally represented, for the purpose of defending such interests against the combinations of majorities in the Assembly.

      §§. 21-36 & § 91(1) of the Constitution Act, 1867

      Referenced in Re: Authority of Parliament in relation to the Upper House, [1980] 1 SCR 54, 1979 CanLII 169 (SCC)

    1. But the very essence of our compact is that the union shall be federal and not legislative. Our Lower Canada friends have agreed to give us representation by population in the Lower House, on the express condition that they shall have equality in the Upper House. On no other condition could we have advanced a step ; and, for my part, I am quite willing they should have it. In maintaining the existing sectional boundaries and handing over the control of local matters to local bodies, we recognize, to a certain extent, a diversity of interests ; and it was quite natural that the protection for those interests, by equality in the Upper Chamber, should be demanded by the less numerous provinces.

      §§. 21-36 & § 91(1) of the Constitution Act, 1867

      Referenced in Re: Authority of Parliament in relation to the Upper House, [1980] 1 SCR 54, 1979 CanLII 169 (SCC)

    1. HON. MR. VIDAL—I am not speaking of the mode of selection. (Hear, hear.)— Twenty-one members of this Legislative Council are to be told that they are no longer wanted. Are they to be those called by Her Majesty in former times to sit here, or those representing the people? It seems to me only fair that those who hold appointments from the Crown for life are entitled to retain their seats, to go first into the new House, and the rejection will then be of the elected members. It will involve nearly half of these, and it is quite obvious that it places all honorable members of this Chamber in a very anomalous position to be called upon to vote on such a question as this.

      §.25 of the Constitution Act, 1867.

    2. HON. MR. VIDAL—In compelling the first selection of legislative councillors from the members of the Chamber, the Conference have put a restraint on the prerogative of the Crown which they had no right to impose. I am unwilling for a moment to suppose that any low or unworthy motive actuated the Canadian delegate?, who alone are responsible for this detail, or that they did this in hopes of securing the votes of any members of this House in favor of their scheme, which they could not otherwise have been sure of; still that part of the scheme has an awkward appearance, and some honorable members may feel with the member from Wellington (Hon. Mr. SANBORN), that if it be not a bribe, it looks something very like it. I, however, do not see it in that light.

      §.25 of the Constitution Act, 1867.

    3. A simple question was put to the Hon. Commissioner of Crown Lands as to the manner in which the members of the Legislative Councils of the various provinces were to be appointed. The Hon. Commissioner informed us that the appointments were to be made by the local governments, and he was confirmed in that view by the hon. and gallant Premier, who had the dignity conferred upon him of presiding over the Conference of delegates held in this city. HON. MR. CAMPBELL—I do not think that my hon. colleague said anything on the subject.

      §.25 of the Constitution Act, 1867.

    1. to be believed that, as promised in the document we are considering, such a Government as we have ” will take care of the Opposition, or consider their right to be represented in the Council?” (Hear, and laughter.) Sir, I thank the delegates for their kind solicitude for the Opposition, but I do not believe they will do anything of the kind. Have we not heard the Honorable Attorney General West, a few nights ago, state, turning to his followers, ” If I were to advise the nomination, I should advise the selection of the best men I could find—and of course of my own party ?” (Hear.) So it will be, sir ; and, if this precious scheme is carried, we shall have a Legislative Council divided in the following proportion :—For Upper Canada, we should probably have liberals in the proportion of three to nine ; for I suppose the honorable member for South Oxford has made sacrifices enough to deserve at least that consideration, and, as his friends compose one-fourth of the Executive Council, I dare say we should get one fourth of the Upper Canada Legislative Councillors liberal too. HON. ATTY. GEN. MACDONALD—Hear, hear HON. MR. HOLTON—Just 25 per cent. HON. MR. DORION—Just 25 per cent, of liberals for Upper Canada. Then, in addition, we should get from Nova Scotia ten conservative, from Prince Edward Island four more, and four from Newfoundland. Thus we shall have eighteen conservatives from the Lower Provinces, which, added to thirty-six from Canada, would make fifty-four conservatives against twenty-two liberals, taking the ten New Brunswick councillors to be all liberals. Now, supposing three per cent, as the average number of deaths per annum—the average proportion of change— it would take nearly thirty years to bring about a change in the character of a majority of the Council, even supposing all the additions made to it to be from the liberal ranks. But, sir, that will hardly be the case. In some of the Lower Provinces there will be Conservative governments now and then, and there may occasionally be conservative governments in Canada. (Hear, and laughter.) So this generation will certainly pass away before the views of the Liberal party will ever find expression in the decisions of the Upper House.

      §§.24, 25, and 26 of the Constitution Act, 1867.

    2. Were we not expressly told that it was the Lower Provinces who would not hear of our having an elective Legislative Council ? If, instead of going into Conference with the people of the Lower Provinces, our Government had done what they pledged themselves to do, that is, to prepare a Constitution themselves, they would never have dared to bring in such a proposition as this which is now imposed upon us by the Lower Colonies —to have a Legislative Council, with a fixed number of members, nominated by four Tory governments. Why, taking the average time each councillor will be in the Council to be fifteen to twenty years, it will take a century before its complexion can be changed. For all time to come, so far as this generation and the next are concerned, you will find the Legislative Council controlled by the influence of the present Government. And is it

      §§.24 and 25 of the Constitution Act, 1867.

    1. to serve ; such members shall he appointed by the Crown at the recommendation of the General Executive Government, upon the nomination of the several local governments, and in such nomination due regard shall be had to the claims of the members of the Legislative Council of the Opposition in each province, so that all political parties may, as nearly as possible, be fairly represented. This shows you the spirit in which these resolutions were framed. Certainly the gentlemen who composed the Conference were, like ourselves, liable to err, but there is no doubt in my mind that they acted conscientiously from beginning to end. Well, honorable gentlemen, after the burning of the Parliament House in Montreal, the greatest possible excitement was created all over the province. Those who were most displeased at the passing of the Rebellion Losses Bill, condemned in the most violent terms the swamping, as they called it, of the Legislative Council, though after all it was nothing to be condemned, seeing that it simply, to some extent, re-established the equilibrium. But it was called, in the furor of the moment, the disgraceful swamping of the Legislative Council, and there was great agitation all over the country. Well, by means of the press constantly hammering away upon what had been done by the Government, and representing those who had been appointed as mere machines and tools of the Executive, although they were really among the most respectable and intelligent in Canada—but party passion does not reason— the people were led to believe that the Legislative Council had been disgraced by the appointment of these twelve additional members. But during the time that the conservatives were, on the one hand, thus battering down the Legislative Council, what had we on the other hand ? We had the old Reform party in Lower Canada beginning to recall their old hatred to the Legislative Council. Although there was no reason to complain after the introduction of responsible government, yet people followed not their reason but their prejudice. So that the Legislative Council received a cross-fire from both sides. I t was being battered down by public opinion on either hand, and what could it do ? Nothing, but come down lower and lower in public estimation. Although the consciences of the members reproached them nothing—although they could walk the streets with their heads erect, yet the Legislative Council had been so much reduced in public opinion, that those gentlemen were really, I will not say ashamed, but reluctant to attend in their places. But, besides, they came not to receive remuneration or salary. From the time they were appointed in 1841, they sacrificed their time and their money, and gave their services gratuitously to the public ; and they were met, as I have already stated, by this universal deluge of abuse which was levelled against them. (Hear, hear.) There was therefore no great encouragement for them to attend in their places in the Legislative Council. But what have we seen since? Session after session, day after day, week after week, we saw the Speaker come into the Council with great pomp, as the Speaker always does come into the Council—(hear, hear, and a laugh)—preceded by the mace ; and after the Speaker had made his usual dutiful bow to the Throne, he would take his seat and remain quietly in the chair for the space of one hour. At the end of the hour, he would consult his watch, and saying there was no quorum present— although surely the quorum was a very small one, being ten members only—he would declare the House adjourned until the following day.

      §§.24 and 25 of the Constitution Act, 1867.

    2. Well, honorable gentlemen, to understand how we stood in 1856 it is necessary we should take the history of the Legislative Council a little further back—from the time of its formation immediately after the union. We had not responsible government at the time of the union, but then it was that the whole system was put in practice. The first batch of councillors were appointed in 1841, and were 25 in number ; but two of them never attended. Out of these 25 there were 18 conservatives and five reformers. In 1842 seven new councillors were added, five conservatives and two reformers. In 1843 the Government changed, and the change made a little difference in the political bearing of the appointments, so that in 1843, there were appointed one conservative and five reformers. In 1844- 45 there were two appointments—two reformers. In 1846 there was one conservative. In 1847 there were four conservatives. Therefore, in 1848, when the Liberal Government came into power—the LAFONTAINE-BALDWIN Administration—the fact was that their partisans in the Legislative Council were fifteen less than the opposite party. (Hear, hear.) What were the Reform Government to do ? They were forced to appoint a large batch this time. They appointed no less than twelve gentlemen. But still it left a majority to the conservative party of three. And if the conservatives had been true to themselves —and I wish to God they had been, and I will tell you, by and by, why — they could have prevented a good deal of trouble and a good deal of agitation in the country. Supposing that what is called the Rebellion Losses Bill had not been passed in 1849, would the country have suffered a great deal .from it? But if the conservatives had been true to themselves they would have stopped the bill. It would have been discussed in all the public prints. The Montrealers would not have been entirely reconciled to the measure, but they would have waived their opinions as dutiful subjects of the Queen, and we should not have witnessed the scandal we had in Montreal—the burning of the Parliamentary buildings and the Representative of the Queen pelted with stones and almost murdered, followed by the annexation movement. But I say if the conservatives had resisted and just postponed the bill for another year, all this trouble might have been avoided. Now, honorable gentlemen, what was the spirit which actuated the appointments to the Council from 1841 to 1848 ? It was a spirit of partisanship, and where there is partisanship there can be no justice. (Hear, hear.) Where there is partisanship there can be no stability — you can depend upon nothing. (Hear, hear.) It is only when justice is rendered to all parties that you can reckon upon stable and permanent governmental institutions. (Hear, hear.) To show the difference between the spirit which actuated these nominations, from 1841 to 1847, and the spirit which exists now, it is only necessary to refer to the resolutions of the Conference. The fourteenth resolution says : The first selection of the members of the Legislative Council shall be made, except as regards Prince Edward Island, from the Legislative Councils of the various provinces, so far as a sufficient number be found qualified and willing

      §.25 of the Constitution Act, 1867.

    3. But, honorable gentlemen, I think that when I shall have explained the circumstances which then forced the Government to bring forward the measure to render this House elective, you will agree with me that it was not on account of any fancy or predilection on their part that the elective system was proposed, but that it was necessitated by the circumstances in which the country found itself placed. It is from no levity in the minds of the members of the Government, or in my own mind ; nor is there any inconsistency in what I then did and in what I am now doing. But we will have something more on that point in the course of a few moments.

      §.25 of the Constitution Act, 1867.

    4. Many of us have been appointed for life in this House, and some of us were so appointed many years back. Here, for instance, is my honorable friend on the left (Hon. Mr. HAMILTON) who has been a member of the House some twenty-four years—who was among the first appointed by Lord SYDENHAM; and I see on the other side, honorable gentlemen also far advanced in years—men who, in the ordinary course of life, cannot expect to be very long with us. Will the honorable gentleman propose to give to the provinces below the right to appoint old gentlemen ? Not a bit of it. They would send here young men—men who are in the prime of life—and when we shall have gone to our last home, these young men from below will be found sitting in your places and in my place. Where, then, would be the equilibrium ? The equilibrium would be lost, and lost for ever. (Hear, hear.) And the honorable gentleman thinks that his amendment would be a great improvement to the scheme of the Conference. Well, for my part, honorable gentlemen, I believe it is a great failure in the way of improving the scheme of the Confederation— a very great failure indeed.

      §.25 of the Constitution Act, 1867.

    5. HON. SIR E. P. TACHÉ—The elective members are a fact accomplished. On the elective principle it is proposed to give a third of the members of the Legislative Council of the Federal Government to the Maritime Provinces. But there are twenty-one life members of this House, and you want to give the Maritime Provinces an equivalent for them.

      §.25 of the Constitution Act, 1867.